Therapy Market Research Reports & Industry Analysis

Defined as treatment of disabilities/illnesses (physical and mental), therapy represents an essential branch of medicine. This term is widely used by psychologists to describe the session between them and patients. Depending on an illness, different therapies types are applied. Therapies may be aimed at the prevention of the disease occurrence, stopping its further progress or preventing an outbreak. They may be also used to improve a patient’s comfort.

Therapies are classified on the basis of energy (e.g. phototherapy and thermotherapy), human interaction (for instance, psychotherapy and psychotherapy) and matter (e.g. gene therapy and biotherapy), etc.

The Catalogue is an unprecedented source of research reports analyzing the therapy market in detail. The reports uncover the market sizing and segmentation, its present standing and future prospects. The research studies investigate the competitive environment and contain majors’ profiles. Market igniters and limiters are scrutinized, and trends and future opportunities are unveiled in the reports.

Found 3565 publications
Gene Therapy Ear Nose Throat Disorders Insight: Pipeline Assessment, Market Trend, Technology and Competitive Landscape US$ 1,000.00

Summary DelveInsight’s Report: Gene Therapy Ear Nose Throat Disorders Insight: Pipeline Assessment, Technology Trend, and Competitive Landscape provides the ... and scope Evaluate the marketing and pipeline strategy for gene therapies and their Funding availabilities. Identifying the upcoming leaders in the ...

Jan, 2015 50 pages
Gene Therapy Genito Urinary System And Sex Hormones Insight: Pipeline Assessment, Market Trend, Technology and Competitive Landscape US$ 1,000.00

... data, technology details, funding and licensing opportunities. The Gene Therapy Genito Urinary System and Sex Hormones Report provides the target ... companies. Studies are performed for approximately 5+ specific indications under Genito Urinary System And Sex Hormones. The Companies are utilizing 4 different ...

Jan, 2015 60 pages
Gene Therapy Dermatology Insight: Pipeline Assessment, Market Trend, Technology and Competitive Landscape US$ 1,000.00

... presentation view. Report facts DelveInsight Gene Therapy Dermatology Report: “Gene Therapy Dermatology Insight: Pipeline Assessment, Market Trend, Technology and ... has highlighted the licensing opportunities and funding details for gene therapies The report also gives the information of dormant and ...

Jan, 2015 60 pages
Gene Therapy Musculoskeletal Insight: Pipeline Assessment, Market Trend, Technology and Competitive Landscape US$ 1,000.00

... demographic presentation view. Report facts DelveInsight Gene Therapy Musculoskeletal Report: “Gene Therapy Musculoskeletal Insight: Pipeline Assessment, Market Trend, Technology and ... also provides the pre-clinical and clinical outcomes of the gene therapies The Report has covered the vector used, target ...

Jan, 2015 65 pages
Gene Therapy Respiratory Insight: Pipeline Assessment, Market Trend, Technology and Competitive Landscape US$ 2,000.00

... presentation view. Report facts DelveInsight Gene Therapy Respiratory Report: “Gene Therapy Respiratory Insight: Pipeline Assessment, Market Trend, Technology and ... has highlighted the licensing opportunities and funding details for gene therapies The report also gives the information of dormant and ...

Jan, 2015 70 pages
Gene Therapy Gastrointestinal Insight: Pipeline Assessment, Market Trend, Technology and Competitive Landscape US$ 2,000.00

... presentation view. Report facts DelveInsight Gene Therapy Gastrointestinal Report: “Gene Therapy Gastrointestinal Insight: Pipeline Assessment, Market Trend, Technology and ... Report also provides the pre-clinical and clinical outcomes of the gene therapies The Report has covered the vector used, target ...

Jan, 2015 70 pages
Gene Therapy Immunology Insight: Pipeline Assessment, Market Trend, Technology and Competitive Landscape US$ 2,000.00

... presentation view. Report facts DelveInsight Gene Therapy Immunology Report: “Gene Therapy Immunology Insight: Pipeline Assessment, Market Trend, Technology and ... Report has highlighted the licensing opportunities and funding details for gene therapies The report also gives the information of dormant and ...

Jan, 2015 75 pages
Gene Therapy Hematological Disorders Insight: Pipeline Assessment, Market Trend, Technology and Competitive Landscape US$ 3,000.00

... demographic presentation view. Report facts DelveInsight Gene Therapy Hematological Disorders Report: “Gene Therapy Hematological Disorders Insight: Pipeline Assessment, Market Trend, ... also provides the pre-clinical and clinical outcomes of the gene therapies The Report has covered the vector used, target ...

Jan, 2015 100 pages
Gene Therapy Cardiovascular Insight: Pipeline Assessment, Market Trend, Technology and Competitive Landscape US$ 3,000.00

... presentation view. Report facts DelveInsight Gene Therapy Cardiovascular Report: “Gene Therapy Cardiovascular Insight: Pipeline Assessment, Market Trend, Technology and ... has highlighted the licensing opportunities and funding details for gene therapies The report also gives the information of dormant and ...

Jan, 2015 100 pages
Gene Therapy Metabolic Disorders Insight: Pipeline Assessment, Market Trend, Technology and Competitive Landscape US$ 3,000.00

... presentation view. Report facts DelveInsight Gene Therapy Metabolic Disorders Report: “Gene Therapy Metabolic Disorders Insight: Pipeline Assessment, Market Trend ... and scope Evaluate the marketing and pipeline strategy for gene therapies and their Funding availabilities. Identifying the upcoming leaders ...

Jan, 2015 115 pages
Gene Therapy Infectious Disease Insight: Pipeline Assessment, Market Trend, Technology and Competitive Landscape US$ 3,000.00

... presentation view. Report facts DelveInsight Gene Therapy Infectious Disease Report: “Gene Therapy Infectious Disease Insight: Pipeline Assessment, Market Trend, ... and scope Evaluate the marketing and pipeline strategy for gene therapies and their Funding availabilities. Identifying the upcoming leaders ...

Jan, 2015 115 pages
Gene Therapy Ophthalmology Insight: Pipeline Assessment, Market Trend, Technology and Competitive Landscape US$ 3,000.00

... presentation view. Report facts DelveInsight Gene Therapy Ophthalmology Report: “Gene Therapy Ophthalmology Insight: Pipeline Assessment, Market Trend, Technology and ... has highlighted the licensing opportunities and funding details for gene therapies The report also gives the information of dormant and ...

Jan, 2015 130 pages
Gene Therapy Central Nervous System Insight: Pipeline Assessment, Market Trend, Technology and Competitive Landscape US$ 3,000.00

... view. Report facts DelveInsight Gene Therapy Central Nervous System Report: “Gene Therapy Central Nervous System Insight: Pipeline Assessment, Market Trend, ... . The Report is also giving insights about the vectors usage in Gene therapy which is approximately 70% for viral vectors, 21% for RNAi therapeutics ...

Jan, 2015 160 pages
Gene Therapy Oncology Insight: Pipeline Assessment, Market Trend, Technology and Competitive Landscape US$ 3,500.00

... presentation view. Report facts DelveInsight Gene Therapy Oncology Report: “Gene Therapy Oncology Insight: Pipeline Assessment, Market Trend, Technology and ... and their Funding availabilities. Identifying the upcoming leaders in the gene therapy market in the coming years. Getting a first mover advantage ...

Jan, 2015 190 pages
Gene Therapy Insight: Pipeline Assessment, Technology Trend, and Competitive Landscape US$ 15,000.00

... in a demographic presentation view. Report facts DelveInsight Report, “Gene Therapy Insight: Pipeline Assessment, Market Trend, Technology and Competitive Landscape” provides ... Report also provides the pre-clinical and clinical outcomes of the gene therapies The Report has covered the vector used, target ...

Jan, 2015 778 pages
Therapeutic Class Overview: Moderate to Severe Pain: Novel Abuse Deterrent Formulation Technologies and Emergence of Novel Mechanisms in the Management of Pain US$ 3,000.00

... targets. A significant unmet need exists in the emergence of novel mechanism which will avoid the current NSAIDS side effects with improved efficacy. ... ability to replace opioids in the treatment of acute and chronic moderate to severe pain. Globally, pain is one of the important therapy areas with a market ...

Jan, 2015 64 pages
Sickle-cell Anemia Therapeutics Market in the US 2015-2019 US$ 2,500.00

... groups and geographical locations. TechNavio's analysts forecast the Sickle-cell Anemia Therapeutics market in the US to grow at a CAGR of 17.10 percent over the period ... Medical Needs For a full, detailed list, view our report Market Challenge Side Effects Associated with Current Therapies For a full, ...

Jan, 2015 51 pages
Global Ankylosing Spondylitis Market 2015-2019 US$ 3,000.00

... developed for the treatment of Ankylosing Spondylitis have been discussed. TechNavio's report, Global Ankylosing Spondylitis Market 2015-2019, has been prepared ... report also includes a discussion on the key vendors operating in this market. Key Regions Americas APAC EMEA Key Vendors Abbvie Amgen ...

Jan, 2015 102 pages
Venous (Vein) Thrombosis - Pipeline Review, H2 2014 US$ 2,000.00

... Review, H2 2014’, provides an overview of the Venous (Vein) Thrombosis’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for ... ) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the ...

Dec, 2014 91 pages
Status Epilepticus - Pipeline Review, H2 2014 US$ 2,000.00

... Summary Global Markets Direct’s, ‘Status Epilepticus - Pipeline Review, H2 2014’, provides an overview of the Status Epilepticus’s therapeutic pipeline. This report provides ... ) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the ...

Dec, 2014 41 pages
Pre-Eclampsia - Pipeline Review, H2 2014 US$ 2,000.00

... Summary Global Markets Direct’s, ‘Pre-Eclampsia - Pipeline Review, H2 2014’, provides an overview of the Pre-Eclampsia’s therapeutic pipeline. This report provides ... news and press releases. It also reviews key players involved in the therapeutic development for Pre-Eclampsia and special features on late ...

Dec, 2014 50 pages
Posterior Uveitis - Pipeline Review, H2 2014 US$ 2,000.00

... 2014 Summary Global Markets Direct’s, ‘Posterior Uveitis - Pipeline Review, H2 2014’, provides an overview of the Posterior Uveitis’s therapeutic pipeline. This report provides ... ) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the ...

Dec, 2014 55 pages
Pancreatic Endocrine Tumor - Pipeline Review, H2 2014 US$ 2,000.00

... Review, H2 2014’, provides an overview of the Pancreatic Endocrine Tumor’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for ... ) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the ...

Dec, 2014 61 pages
Pacific Therapeutics Ltd. - Product Pipeline Review - 2014 US$ 1,500.00

... disease. Scope The report provides brief overview of Pacific Therapeutics Ltd. including business description, key information and facts, and its ... and discontinued pipeline projects Latest company statement Latest news and deals relating to the Pacific Therapeutics Ltd.’s pipeline products Reasons ...

Dec, 2014 23 pages
NovaRx Corporation - Product Pipeline Review - 2014 US$ 1,500.00

... description, key information and facts, and its locations and subsidiaries The report reviews current pipeline of NovaRx Corporation’s human therapeutic ... all the dormant and discontinued pipeline projects Latest company statement Latest news and deals relating to the NovaRx Corporation’s pipeline products ...

Dec, 2014 21 pages
NovaDigm Therapeutics, Inc. - Product Pipeline Review - 2014 US$ 1,500.00

... action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with ... dormant and discontinued pipeline projects Latest company statement Latest news and deals relating to the NovaDigm Therapeutics, Inc.’s pipeline products Reasons ...

Dec, 2014 21 pages
Nordic Bioscience a/s - Product Pipeline Review - 2014 US$ 1,500.00

... and its locations and subsidiaries The report reviews current pipeline of Nordic Bioscience a/s’s human therapeutic division and enlists all their major ... the dormant and discontinued pipeline projects Latest company statement Latest news and deals relating to the Nordic Bioscience a/s’s pipeline products ...

Dec, 2014 26 pages
NKT Therapeutics, Inc. - Product Pipeline Review - 2014 US$ 1,500.00

... indicated disease. Scope The report provides brief overview of NKT Therapeutics, Inc. including business description, key information and facts, and its ... and discontinued pipeline projects Latest company statement Latest news and deals relating to the NKT Therapeutics, Inc.’s pipeline products Reasons ...

Dec, 2014 20 pages
Muscle Spasticity - Pipeline Review, H2 2014 US$ 2,000.00

... 2014 Summary Global Markets Direct’s, ‘Muscle Spasticity - Pipeline Review, H2 2014’, provides an overview of the Muscle Spasticity’s therapeutic pipeline. This report provides ... ) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the ...

Dec, 2014 48 pages
Muscle Spasm - Pipeline Review, H2 2014 US$ 2,000.00

... 2014 Summary Global Markets Direct’s, ‘Muscle Spasm - Pipeline Review, H2 2014’, provides an overview of the Muscle Spasm’s therapeutic pipeline. This report provides ... news and press releases. It also reviews key players involved in the therapeutic development for Muscle Spasm and special features on late ...

Dec, 2014 35 pages
Lumosa Therapeutics Co., Ltd. - Product Pipeline Review - 2014 US$ 1,500.00

... action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with ... and discontinued pipeline projects Latest company statement Latest news and deals relating to the Lumosa Therapeutics Co., Ltd.’s pipeline products Reasons to ...

Dec, 2014 24 pages
Kaposi's Sarcoma - Pipeline Review, H2 2014 US$ 2,000.00

... Summary Global Markets Direct’s, ‘Kaposi's Sarcoma - Pipeline Review, H2 2014’, provides an overview of the Kaposi's Sarcoma’s therapeutic pipeline. This report provides ... key players involved in the therapeutics development for Kaposi's Sarcoma and enlists all their major and minor projects The report ...

Dec, 2014 31 pages
Inclusion Body Myositis (IBM) - Pipeline Review, H2 2014 US$ 2,000.00

... , H2 2014’, provides an overview of the Inclusion Body Myositis (IBM)’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for ... Body Myositis (IBM) The report reviews key pipeline products under drug profile section which includes, product description, MoA and ...

Dec, 2014 52 pages
Heron Therapeutics, Inc. - Product Pipeline Review - 2014 US$ 1,500.00

... disease. Scope The report provides brief overview of Heron Therapeutics, Inc. including business description, key information and facts, and its ... and discontinued pipeline projects Latest company statement Latest news and deals relating to the Heron Therapeutics, Inc.’s pipeline products Reasons to ...

Dec, 2014 29 pages
Gastrointestinal Radiation Toxicity - Pipeline Review, H2 2014 US$ 2,000.00

... Direct’s, ‘Gastrointestinal Radiation Toxicity - Pipeline Review, H2 2014’, provides an overview of the Gastrointestinal Radiation Toxicity’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Gastrointestinal Radiation Toxicity, complete with comparative ...

Dec, 2014 47 pages
CytomX Therapeutics, Inc. - Product Pipeline Review - 2014 US$ 1,500.00

... disease. Scope The report provides brief overview of CytomX Therapeutics, Inc. including business description, key information and facts, and its ... and discontinued pipeline projects Latest company statement Latest news and deals relating to the CytomX Therapeutics, Inc.’s pipeline products Reasons ...

Dec, 2014 30 pages
Chronic Coronary Artery Disease (CAD) (Ischemic Heart Disease) - Pipeline Review, H2 2014 US$ 2,000.00

... new targets and MOAs to produce first-in-class and best-in-class products. Note: Certain sections in the report may be removed or altered based ... and discontinued pipeline projects A review of the Chronic Coronary Artery Disease (CAD) (Ischemic Heart Disease) products under development by companies and ...

Dec, 2014 44 pages
Chlamydia Trachomatis Infections - Pipeline Review, H2 2014 US$ 2,000.00

... Markets Direct’s, ‘Chlamydia Trachomatis Infections - Pipeline Review, H2 2014’, provides an overview of the Chlamydia Trachomatis Infections’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Chlamydia Trachomatis Infections, complete with comparative ...

Dec, 2014 38 pages
C3 Jian, Inc - Product Pipeline Review - 2014 US$ 1,500.00

... business description, key information and facts, and its locations and subsidiaries The report reviews current pipeline of C3 Jian, Inc’s human therapeutic ... all the dormant and discontinued pipeline projects Latest company statement Latest news and deals relating to the C3 Jian, Inc’s pipeline products ...

Dec, 2014 29 pages
Burkholderia Pseudomallei Infections - Pipeline Review, H2 2014 US$ 2,000.00

... Markets Direct’s, ‘Burkholderia Pseudomallei Infections - Pipeline Review, H2 2014’, provides an overview of the Burkholderia Pseudomallei Infections’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Burkholderia Pseudomallei Infections, complete with ...

Dec, 2014 45 pages
Becker Muscular Dystrophy - Pipeline Review, H2 2014 US$ 2,000.00

... Review, H2 2014’, provides an overview of the Becker Muscular Dystrophy’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for ... ) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the ...

Dec, 2014 40 pages
Aortic Aneurysm - Pipeline Review, H2 2014 US$ 2,000.00

... 2014 Summary Global Markets Direct’s, ‘Aortic Aneurysm - Pipeline Review, H2 2014’, provides an overview of the Aortic Aneurysm’s therapeutic pipeline. This report provides ... key players involved in the therapeutics development for Aortic Aneurysm and enlists all their major and minor projects The report ...

Dec, 2014 53 pages
Global Acute Myeloid Leukemia Therapeutics Market 2015-2019 US$ 2,500.00

... node, liver, brain, spinal cord and testicles. Clonal expansion of the myeloid blasts and the loss of normal hematopoiesis are the main characteristic ... and a corresponding detailed analysis of the top vendors in the Global Acute Myeloid Leukemia Therapeutics market. In addition, the report discusses the major ...

Dec, 2014 88 pages
Epilepsy Therapeutics Market in the APAC Region 2015-2019 US$ 2,500.00

... to diagnose a person as being epileptic. TechNavio's analysts forecast the Epilepsy Therapeutics market in the APAC to grow at a CAGR of 5.78 percent over the period ... sales of anti-epileptic drugs used for the treatment of the symptoms of epilepsy in APAC. The report also presents the vendor landscape and ...

Dec, 2014 86 pages
Global Depression Therapy & Treatment Market – Depression drugs and devices, Anxiety Disorders,  SSRIs, Fischer wallace stimulator, Transcranial magnetic stimulation, Psychoanalysis,... US$ 7,000.00

... Middle Eastern countries have seen the highest prevalence rate of depression whereas North American countries have a moderate prevalence rate, while ... here in the form of all possible treatments. There are various methods to treat depression which include antidepressants drug therapies, various interpersonal ...

Nov, 2014 70 pages
Solvotrin Therapeutics Ltd - Product Pipeline Review - 2014 US$ 1,500.00

... disease. Scope The report provides brief overview of Solvotrin Therapeutics Ltd including business description, key information and facts, and its ... and discontinued pipeline projects Latest company statement Latest news and deals relating to the Solvotrin Therapeutics Ltd’s pipeline products Reasons ...

Dec, 2014 18 pages
Protagonist Therapeutics Inc. - Product Pipeline Review - 2014 US$ 1,500.00

... action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with ... and discontinued pipeline projects Latest company statement Latest news and deals relating to the Protagonist Therapeutics Inc.’s pipeline products Reasons to ...

Dec, 2014 28 pages
Melinta Therapeutics, Inc - Product Pipeline Review - 2014 US$ 1,500.00

... disease. Scope The report provides brief overview of Melinta Therapeutics, Inc including business description, key information and facts, and its ... and discontinued pipeline projects Latest company statement Latest news and deals relating to the Melinta Therapeutics, Inc’s pipeline products Reasons ...

Dec, 2014 49 pages
Amarna Therapeutics B.V. - Product Pipeline Review - 2014 US$ 1,500.00

... action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with ... all the dormant and discontinued pipeline projects Latest company statement Latest news and deals relating to the Amarna Therapeutics B.V.’s pipeline products ...

Dec, 2014 23 pages
Type 2 Diabetes Therapeutics in Asia-Pacific Markets to 2020 - Increasing Uptake of Novel Drug Classes to Drive Market Growth US$ 4,995.00

... business intelligence provider, has released its latest research, “Type 2 Diabetes Therapeutics in Asia-Pacific Markets to 2020 - Increasing Uptake of Novel Drug Classes to ... size, trial duration and program failure rate for each molecule type Multi-scenario market forecast data to 2020, taking into account ...

Nov, 2014 107 pages
1 2 3 4 5 >
Skip to top